Your browser doesn't support javascript.
loading
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.
Langley, Richard G B; Reich, Kristian; Strand, Vibeke; Feldman, Steven R; Paul, Carle; Gordon, Kenneth; Warren, Richard B; Toth, Darryl; Nikaï, Enkeleida; Zhu, Baojin; Goldblum, Orin; Edson-Heredia, Emily; Carlier, Hilde; Burge, Russel; Lin, Chen-Yen; Hollister, Kristin; Augustin, Matthias.
Afiliação
  • Langley RGB; Division of Dermatology, Department of Medicine, Dalhousie University, 6054 Coburg Road, Halifax, NS, Canada. richardgblangley@gmail.com.
  • Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, and Skinflammation® Center, Hamburg, Germany.
  • Strand V; Biopharmaceutical Consultant, Portola Valley, CA, USA.
  • Feldman SR; Wake Forest University Health Sciences, Winston-Salem, NC, USA.
  • Paul C; Toulouse University, Toulouse, France.
  • Gordon K; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Warren RB; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Toth D; Probity Medical Research, Windsor, ON, Canada.
  • Nikaï E; Eli Lilly Benelux S.A., Brussels, Belgium.
  • Zhu B; Eli Lilly and Company, Indianapolis, IN, USA.
  • Goldblum O; Eli Lilly and Company, Indianapolis, IN, USA.
  • Edson-Heredia E; Eli Lilly and Company, Indianapolis, IN, USA.
  • Carlier H; Eli Lilly Benelux S.A., Brussels, Belgium.
  • Burge R; Eli Lilly and Company, Indianapolis, IN, USA.
  • Lin CY; Eli Lilly and Company, Indianapolis, IN, USA.
  • Hollister K; Eli Lilly and Company, Indianapolis, IN, USA.
  • Augustin M; Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg, Hamburg, Germany.
Qual Life Res ; 29(2): 369-380, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31655974
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Interleucina-17 / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Interleucina-17 / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá